Skip to content
GovLens is in free beta — full access while we build. Join the beta →
Feed/DEC2019/2103(DEC)Finance & Budget

2018 Discharge: Innovative Medicines Initiative 2 (IMI 2)

COMCMT1R-EP1R-C2R-EPCNCADO
Updated 69mo ago
View source

This procedure concerns the European Parliament's decision on the financial management of the Innovative Medicines Initiative 2 (IMI 2) Joint Undertaking for the year 2018. It assesses whether the undertaking managed its budget responsibly and effectively.

This decision affects the IMI 2 Joint Undertaking and its stakeholders involved in pharmaceutical research and innovation. It ensures accountability in the use of public funds for collaborative research projects.

Documents

2018 discharge: Joint undertaking - Innovative Medicines Initiative 2 (IMI 2)

position · EN · 2026-05-03

2018 discharge: Joint undertaking - Innovative Medicines Initiative 2 (IMI 2)

proposal · EN · 2026-05-03

2018 discharge: Joint undertaking - Innovative Medicines Initiative 2 (IMI 2)

motion · EN · 2026-05-03

2018 discharge: Joint undertaking - Innovative Medicines Initiative 2 (IMI 2)

proposal · EN · 2026-05-03

2018 discharge: Joint undertaking - Innovative Medicines Initiative 2 (IMI 2)

proposal · EN · 2026-05-03

2018 discharge: Joint undertaking - Innovative Medicines Initiative 2 (IMI 2)

proposal · EN · 2026-05-03

2018 discharge: Joint undertaking - Innovative Medicines Initiative 2 (IMI 2)

proposal · EN · 2026-05-03

2018 discharge: Joint undertaking - Innovative Medicines Initiative 2 (IMI 2)

proposal · EN · 2026-05-03

2018 discharge: Joint undertaking - Innovative Medicines Initiative 2 (IMI 2)

proposal · EN · 2026-05-03

2018 discharge: Joint undertaking - Innovative Medicines Initiative 2 (IMI 2)

proposal · EN · 2026-05-03

2018 discharge: Joint undertaking - Innovative Medicines Initiative 2 (IMI 2)

proposal · EN · 2026-05-03

2018 discharge: Joint undertaking - Innovative Medicines Initiative 2 (IMI 2)

proposal · EN · 2026-05-03

2018 discharge: Joint undertaking - Innovative Medicines Initiative 2 (IMI 2)

proposal · EN · 2026-05-03

2018 discharge: Joint undertaking - Innovative Medicines Initiative 2 (IMI 2)

motion · EN · 2026-05-03

2018 discharge: Joint undertaking - Innovative Medicines Initiative 2 (IMI 2)

proposal · EN · 2026-05-03

2018 discharge: Joint undertaking - Innovative Medicines Initiative 2 (IMI 2)

motion · EN · 2026-05-03

2018 discharge: Joint undertaking - Innovative Medicines Initiative 2 (IMI 2)

proposal · EN · 2026-05-03

2018 discharge: Joint undertaking - Innovative Medicines Initiative 2 (IMI 2)

proposal · EN · 2026-05-03

2018 discharge: Joint undertaking - Innovative Medicines Initiative 2 (IMI 2)

proposal · EN · 2026-05-03

2018 discharge: Joint undertaking - Innovative Medicines Initiative 2 (IMI 2)

proposal · EN · 2026-05-03

2018 discharge: Joint undertaking - Innovative Medicines Initiative 2 (IMI 2)

proposal · EN · 2026-05-03

2018 discharge: Joint undertaking - Innovative Medicines Initiative 2 (IMI 2)

proposal · EN · 2026-05-03

2018 discharge: Joint undertaking - Innovative Medicines Initiative 2 (IMI 2)

proposal · EN · 2026-05-03

2018 discharge: Joint undertaking - Innovative Medicines Initiative 2 (IMI 2)

proposal · EN · 2026-05-03

2018 discharge: Joint undertaking - Innovative Medicines Initiative 2 (IMI 2)

motion · EN · 2026-05-03

2018 discharge: Joint undertaking - Innovative Medicines Initiative 2 (IMI 2)

proposal · EN · 2026-05-03

2018 discharge: Joint undertaking - Innovative Medicines Initiative 2 (IMI 2)

proposal · EN · 2026-05-03

2018 discharge: Joint undertaking - Innovative Medicines Initiative 2 (IMI 2)

proposal · EN · 2026-05-03

2018 discharge: Joint undertaking - Innovative Medicines Initiative 2 (IMI 2)

proposal · EN · 2026-05-03

2018 discharge: Joint undertaking - Innovative Medicines Initiative 2 (IMI 2)

proposal · EN · 2026-05-03

2018 discharge: Joint undertaking - Innovative Medicines Initiative 2 (IMI 2)

proposal · EN · 2026-05-03

2018 discharge: Joint undertaking - Innovative Medicines Initiative 2 (IMI 2)

motion · EN · 2026-05-03

2018 discharge: Joint undertaking - Innovative Medicines Initiative 2 (IMI 2)

proposal · EN · 2026-05-03

2018 discharge: Joint undertaking - Innovative Medicines Initiative 2 (IMI 2)

proposal · EN · 2026-05-03

2018 discharge: Joint undertaking - Innovative Medicines Initiative 2 (IMI 2)

proposal · EN · 2026-05-03

2018 discharge: Joint undertaking - Innovative Medicines Initiative 2 (IMI 2)

proposal · EN · 2026-05-03

2018 discharge: Joint undertaking - Innovative Medicines Initiative 2 (IMI 2)

motion · EN · 2026-05-03

2018 discharge: Joint undertaking - Innovative Medicines Initiative 2 (IMI 2)

proposal · EN · 2026-05-03

2018 discharge: Joint undertaking - Innovative Medicines Initiative 2 (IMI 2)

proposal · EN · 2026-05-03

2018 discharge: Joint undertaking - Innovative Medicines Initiative 2 (IMI 2)

proposal · EN · 2026-05-03

2018 discharge: Joint undertaking - Innovative Medicines Initiative 2 (IMI 2)

proposal · EN · 2026-05-03

2018 discharge: Joint undertaking - Innovative Medicines Initiative 2 (IMI 2)

motion · EN · 2026-05-03

2018 discharge: Joint undertaking - Innovative Medicines Initiative 2 (IMI 2)

proposal · EN · 2026-05-03

2018 discharge: Joint undertaking - Innovative Medicines Initiative 2 (IMI 2)

proposal · EN · 2026-05-03

2018 discharge: Joint undertaking - Innovative Medicines Initiative 2 (IMI 2)

proposal · EN · 2026-05-03

2018 discharge: Joint undertaking - Innovative Medicines Initiative 2 (IMI 2)

proposal · EN · 2026-05-03

2018 discharge: Joint undertaking - Innovative Medicines Initiative 2 (IMI 2)

proposal · EN · 2026-05-03

2018 discharge: Joint undertaking - Innovative Medicines Initiative 2 (IMI 2)

proposal · EN · 2026-05-03

2018 discharge: Joint undertaking - Innovative Medicines Initiative 2 (IMI 2)

proposal · EN · 2026-05-03

2018 discharge: Joint undertaking - Innovative Medicines Initiative 2 (IMI 2)

proposal · EN · 2026-05-03